Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 54.1B | 50.5B | 52.5B | 41.0B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 41.4B | 12.9B | 18.0B | 20.0B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 29.9B | 26.6B | 24.7B | 25.5B |
Tax provision | 9.2B | 7.3B | 6.2B | 8.1B |
Net income | 20.9B | 19.5B | 18.7B | 17.4B |
Basic EPS | — | 1.8 | 1.7 | 1.6 |
Diluted EPS | — | 1.8 | 1.7 | 1.6 |
Basic average shares | — | 10.8B | 10.8B | 10.8B |
Diluted average shares | — | 10.8B | 10.8B | 10.8B |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -67.9M | -55.5M | -84.7M | -48.3M |
Preferred stock dividends | — | — | — | — |